Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal

1982 ◽  
Vol 107 (6) ◽  
pp. 631-640 ◽  
Author(s):  
LIONEL FRY ◽  
J.N. LEONARD ◽  
FRANCES SWAIN ◽  
W.F.G. TUCKER ◽  
G. HAFFENDEN ◽  
...  
1986 ◽  
Vol 15 (1) ◽  
pp. 24-30 ◽  
Author(s):  
Elisa Ermacora ◽  
Luigia Prampolini ◽  
Giuliana Tribbia ◽  
Gabriella Pezzoli ◽  
Carlo Gelmetti ◽  
...  

2013 ◽  
Vol 26 (1-2) ◽  
Author(s):  
Lorete Maria da Silva Kotze ◽  
Renato Nisihara ◽  
Luiz Roberto Kotze ◽  
Shirley Ramos da Rosa Utiyama

2014 ◽  
Vol 171 (5) ◽  
pp. 1242-1243 ◽  
Author(s):  
K. Hervonen ◽  
T.T. Salmi ◽  
K. Kurppa ◽  
K. Kaukinen ◽  
P. Collin ◽  
...  

Nutrients ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 1060
Author(s):  
Anna Alakoski ◽  
Kaisa Hervonen ◽  
Eriika Mansikka ◽  
Timo Reunala ◽  
Katri Kaukinen ◽  
...  

The treatment of choice for dermatitis herpetiformis (DH), a cutaneous manifestation of coeliac disease, is a life-long gluten-free diet (GFD). In a GFD, wheat, rye and barley should be strictly avoided, but the role of oats is more controversial. This study aimed to investigate the safety and long-term quality of life and health effects of oat consumption in 312 long-term treated DH patients. Baseline data were gathered from patient records and follow-up data from questionnaires or interviews, and validated questionnaires were used to assess quality of life. We found that altogether 256 patients (82%) were consuming oats as part of their GFD at the follow-up. Long-term follow-up data showed that there were no differences in the presence of long-term illnesses, coeliac disease complications or the usage of medication between those consuming and not consuming oats. However, oat consumers had a better quality of life and reported ongoing gastrointestinal symptoms less frequently (4% vs 19%, p = 0.004) at the follow-up than those not consuming oats. The study established that oats are safe for DH patients and in the long-term seem to improve the quality of life of DH patients.


2019 ◽  
Vol 42 ◽  
Author(s):  
John P. A. Ioannidis

AbstractNeurobiology-based interventions for mental diseases and searches for useful biomarkers of treatment response have largely failed. Clinical trials should assess interventions related to environmental and social stressors, with long-term follow-up; social rather than biological endpoints; personalized outcomes; and suitable cluster, adaptive, and n-of-1 designs. Labor, education, financial, and other social/political decisions should be evaluated for their impacts on mental disease.


2001 ◽  
Vol 120 (5) ◽  
pp. A397-A397
Author(s):  
M SAMERAMMAR ◽  
J CROFFIE ◽  
M PFEFFERKORN ◽  
S GUPTA ◽  
M CORKINS ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A204-A204
Author(s):  
B GONZALEZCONDE ◽  
J VAZQUEZIGLESIAS ◽  
L LOPEZROSES ◽  
P ALONSOAGUIRRE ◽  
A LANCHO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document